ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 137 filers reported holding ARGENX SE in Q2 2019. The put-call ratio across all filers is 2.14 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,870,652 | +16.1% | 3,805 | -8.0% | 0.00% | 0.0% |
| Q2 2023 | $1,611,534 | +95313.5% | 4,135 | -8.8% | 0.00% | 0.0% |
| Q1 2023 | $1,689 | -1.7% | 4,534 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $1,718 | -100.0% | 4,534 | -83.7% | 0.00% | -75.0% |
| Q3 2022 | $9,798,000 | +483.9% | 27,750 | +526.7% | 0.00% | +300.0% |
| Q2 2022 | $1,678,000 | +44.5% | 4,428 | -14.1% | 0.00% | – |
| Q2 2020 | $1,161,000 | +1.0% | 5,155 | -40.9% | 0.00% | -100.0% |
| Q1 2020 | $1,149,000 | -31.6% | 8,721 | -16.7% | 0.00% | 0.0% |
| Q4 2019 | $1,680,000 | +32.1% | 10,469 | -6.2% | 0.00% | 0.0% |
| Q3 2019 | $1,272,000 | -12.6% | 11,165 | +8.5% | 0.00% | 0.0% |
| Q2 2019 | $1,456,000 | +278.2% | 10,286 | +233.6% | 0.00% | -50.0% |
| Q1 2019 | $385,000 | – | 3,083 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
| Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
| Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
| Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
| Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
| Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
| Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
| DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
| SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
| RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |